BR112013029974A2 - imunoensaio de gencitabina - Google Patents

imunoensaio de gencitabina

Info

Publication number
BR112013029974A2
BR112013029974A2 BR112013029974A BR112013029974A BR112013029974A2 BR 112013029974 A2 BR112013029974 A2 BR 112013029974A2 BR 112013029974 A BR112013029974 A BR 112013029974A BR 112013029974 A BR112013029974 A BR 112013029974A BR 112013029974 A2 BR112013029974 A2 BR 112013029974A2
Authority
BR
Brazil
Prior art keywords
gemcitabine
immunoassay
immunogens
conjugates
antibodies
Prior art date
Application number
BR112013029974A
Other languages
English (en)
Inventor
Spedaliere Christopher
Sard Howard
Blake Courtney Jodi
J Salamone Salvatore
Original Assignee
Saladax Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saladax Biomedical Inc filed Critical Saladax Biomedical Inc
Publication of BR112013029974A2 publication Critical patent/BR112013029974A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • G01N33/1826—Organic contamination in water
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

resumo patente de invenção: "imunoensaio de gencitabina". a presente invenção refere-se a novos conjugados e imunógenos derivados de gencitabina e anticorpos únicos gerados usando imunógenos ligados à gencitabina, em que conjugados, imunógenos e anticorpos são úteis em imunoensaios para a quantificação e monitoramento de gencitabina em fluidos biológicos.
BR112013029974A 2011-05-24 2012-05-07 imunoensaio de gencitabina BR112013029974A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/114,218 US8426143B2 (en) 2011-05-24 2011-05-24 Gemcitabine immunoassay
US13/160,370 US8946392B2 (en) 2011-05-24 2011-06-14 Gemcitabine immunoassay
PCT/US2012/036723 WO2012161948A1 (en) 2011-05-24 2012-05-07 Gemcitabine immunoassay

Publications (1)

Publication Number Publication Date
BR112013029974A2 true BR112013029974A2 (pt) 2017-01-31

Family

ID=47217602

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013029974A BR112013029974A2 (pt) 2011-05-24 2012-05-07 imunoensaio de gencitabina

Country Status (7)

Country Link
US (3) US8426143B2 (pt)
EP (1) EP2715340A4 (pt)
JP (1) JP2014519036A (pt)
CN (1) CN103782167B (pt)
BR (1) BR112013029974A2 (pt)
CA (1) CA2836539A1 (pt)
WO (1) WO2012161948A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426143B2 (en) * 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay
EP3383406B1 (en) 2015-12-03 2021-10-20 Epidestiny, Inc. Compositions containing decitabine, 5-azacytidine and tetrahydrouridine and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010200A (en) * 1932-11-17 1935-08-06 Internat Carbonic Engineering Sealing device for pressure containers
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4269511A (en) 1979-02-15 1981-05-26 Abbott Laboratories Apparatus and method for measuring the magnitude of polarization of light
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5101015A (en) 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
CA2096495C (en) 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
US7829064B2 (en) 1999-05-10 2010-11-09 Immunomedics, Inc. Anti-CD74 immunoconjugates and methods
FR2836995B1 (fr) * 2002-03-05 2006-09-22 Centre Nat Rech Scient Utilisation de derives de nucleosides comportant un groupement citrate pour la production d'anticorps ayant une affinite pour des nucleosides triphosphorylees et leurs applications
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US20060177883A1 (en) 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
DE602006015929D1 (de) 2005-03-30 2010-09-16 Saladax Biomedical Inc Doxorubicin-immuntest
US8039220B2 (en) 2008-09-17 2011-10-18 Saladax Biomedical Inc. Stabilized standards for busulfan immunoassay
US8846110B2 (en) 2009-10-13 2014-09-30 Rexahn Pharmaceuticals, Inc. Polymeric systems for the delivery of anticancer drugs
US8426143B2 (en) * 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay

Also Published As

Publication number Publication date
US20120301901A1 (en) 2012-11-29
CN103782167B (zh) 2016-01-20
US20150104818A1 (en) 2015-04-16
US8426143B2 (en) 2013-04-23
JP2014519036A (ja) 2014-08-07
EP2715340A1 (en) 2014-04-09
US20120301902A1 (en) 2012-11-29
EP2715340A4 (en) 2014-12-31
CN103782167A (zh) 2014-05-07
WO2012161948A1 (en) 2012-11-29
US8946392B2 (en) 2015-02-03
CA2836539A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
BR112012023015A2 (pt) imunoensaios para lenalidomida e talidomida
CY1123518T1 (el) Ανθρωπινα αντισωματα enanti-tau
CY1122978T1 (el) Αντισωματα εναντι-vla-4
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
BR112014012275A2 (pt) purificação de proteína com a utilização de tampão bis-tris
BR112015027812A2 (pt) processo contínuo de multietapa para purificação de anticorpos
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
BR112014003501A2 (pt) anticorpos que se ligam à integrina alfa-v beta-8
CR20150102A (es) Anticuerpos que se unen a il-4 y/o il-13 (divisional 2)
BR112014011594A2 (pt) anticorpos anti-il-36r
CY1115932T1 (el) Σκευασμα αντισωματος
BR112012017051A2 (pt) método para diminuir a imunogenicidade
BRPI0821375B8 (pt) anticorpos biespecíficos, bivalentes, processo para a preparação destes e composição farmacêutica dos mesmos
TR201910721T4 (tr) İnsan OX40'a yönelik spesifisiteye sahip olan antikor molekülleri.
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
BR112014010955A2 (pt) sistema e método para processar amostras
CR11783A (es) Molecula de union al antigeno capaz de unirse repetidamente a dos o mas moleculas de antigeno
CR20110238A (es) Anticuerpos muc1*
BR112014028785A2 (pt) proteínas de ligação a antígeno de st2
UY33407A (es) Anticuerpos específicos del factor gdf8 humano
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
GB201202223D0 (en) Immunoassay for pyrrolidinophenones
BR112014005644A2 (pt) anticorpo anti-alfabetatcr
BR112015017354A2 (pt) método para detectar pelo menos uma base modificada
CR20110559A (es) Anticuerpos específicos para cadherina-17

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)